DTL
AIMT

Dynamic Technology Lab’s Aimmune Therapeutics AIMT Stock Holding History

Dynamic Technology Lab’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,486
Closed -$209K – 1490
2020
Q2 		$209K Sell
12,486
-1,628
-12% -$27.6K 0.03% 799
2020
Q1 		$204K Buy
+14,114
New +$361K 0.04% 773
2018
Q1 		– Sell
-7,794
Closed -$295K – 1503
2017
Q4 		$295K Buy
+7,794
New +$251K 0.05% 704
2016
Q2 		– Sell
-16,873
Closed -$229K – 1272
2016
Q1 		$229K Buy
+16,873
New +$263K 0.06% 676

Other funds holding AIMT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dynamic Technology Lab's AIMT Position: Q3 2020 in Review

Dynamic Technology Lab sold out of Aimmune Therapeutics (AIMT) in Q3 2020, closing a stake of 12,486 shares — an estimated $209K sold.

Dynamic Technology Lab first reported a position in AIMT in Q1 2016 and held it in 4 quarters. The position peaked at $295K in Q4 2017. 188 funds tracked by Wall St. Rank hold AIMT as of Q3 2020.

  • Dynamic Technology Lab reported no remaining Aimmune Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Dynamic Technology Lab sold 12,486 Aimmune Therapeutics shares in Q3 2020, an estimated $209K.
  • Dynamic Technology Lab first reported a position in Aimmune Therapeutics in Q1 2016 and held it in 4 quarters.
  • Dynamic Technology Lab's Aimmune Therapeutics position peaked at $295K in Q4 2017.
  • 188 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q3 2020.

Based on Dynamic Technology Lab's 13F filing for Q3 2020, filed 13 Nov 2020.